MAIA Total Cash From Operating Activities from 2010 to 2024
| MAIA Stock | USD 3.85 0.23 6.35% |
Total Cash From Operating Activities | First Reported 2010-12-31 | Previous Quarter -13.1 M | Current Value -12.4 M | Quarterly Volatility 4.4 M |
Check MAIA Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MAIA main balance sheet or income statement drivers, such as Depreciation And Amortization of 0.95, Selling General Administrative of 6.6 M or Selling And Marketing Expenses of 7.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 34.12. MAIA financial statements analysis is a perfect complement when working with MAIA Biotechnology Valuation or Volatility modules.
MAIA | Total Cash From Operating Activities |
Latest MAIA Biotechnology's Total Cash From Operating Activities Growth Pattern
Below is the plot of the Total Cash From Operating Activities of MAIA Biotechnology over the last few years. It is MAIA Biotechnology's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MAIA Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Total Cash From Operating Activities | 10 Years Trend |
|
Total Cash From Operating Activities |
| Timeline |
MAIA Total Cash From Operating Activities Regression Statistics
| Arithmetic Mean | (3,917,492) | |
| Coefficient Of Variation | (113.26) | |
| Mean Deviation | 3,412,951 | |
| Median | (1,565,112) | |
| Standard Deviation | 4,436,815 | |
| Sample Variance | 19.7T | |
| Range | 11.5M | |
| R-Value | (0.74) | |
| Mean Square Error | 9.5T | |
| R-Squared | 0.55 | |
| Significance | 0 | |
| Slope | (737,583) | |
| Total Sum of Squares | 275.6T |
MAIA Total Cash From Operating Activities History
About MAIA Biotechnology Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MAIA Biotechnology income statement, its balance sheet, and the statement of cash flows. MAIA Biotechnology investors use historical funamental indicators, such as MAIA Biotechnology's Total Cash From Operating Activities, to determine how well the company is positioned to perform in the future. Although MAIA Biotechnology investors may use each financial statement separately, they are all related. The changes in MAIA Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MAIA Biotechnology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MAIA Biotechnology Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MAIA Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Cash From Operating Activities | -13.1 M | -12.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MAIA Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MAIA Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maia Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maia Biotechnology Stock:Check out the analysis of MAIA Biotechnology Correlation against competitors. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for MAIA Stock analysis
When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is MAIA Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.49) | Return On Assets (1.29) | Return On Equity (4.40) |
The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.